Literature DB >> 21197228

Validation of 2 commercially available enzyme-linked immunosorbent assays for adiponectin determination in canine serum samples.

Asta Tvarijonaviciute1, Silvia Martínez-Subiela, José J Ceron.   

Abstract

The aim of this study was to validate 2 commercially available enzyme-linked immunosorbent assays (ELISAs) for adiponectin in dogs, 1 canine-specific and 1 originally designed for measurements in humans. Intra-assay and interassay precision was evaluated by multiple measurements in canine serum samples, and assay accuracy was indirectly determined by linearity under dilution. Interference caused by hemolysis and lipemia was also studied. Both assays were subsequently used for measuring adiponectin concentrations in clinically healthy dogs and those with different grades of obesity. The intra-assay and inter-assay precision was less than 7.5% and 13.5% in serum samples with low and high adiponectin concentrations, respectively. Lipemia and hemolysis did not affect the results of any of the assays. Both assays were able to differentiate lean dogs from those that were overweight or obese on the basis of the measured adiponectin concentrations. From these results it can be concluded that canine adiponectin concentrations can be measured reliably by means of the 2 ELISAs evaluated in this study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21197228      PMCID: PMC2949341     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  25 in total

1.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Analytical validation of commercially available methods for acute phase proteins quantification in pigs.

Authors:  F Tecles; P Fuentes; S Martínez Subiela; M D Parra; A Muñoz; J J Cerón
Journal:  Res Vet Sci       Date:  2006-12-01       Impact factor: 2.534

3.  Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages.

Authors:  N Ouchi; S Kihara; Y Arita; M Nishida; A Matsuyama; Y Okamoto; M Ishigami; H Kuriyama; K Kishida; H Nishizawa; K Hotta; M Muraguchi; Y Ohmoto; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  2001-02-27       Impact factor: 29.690

4.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

Authors:  K Hotta; T Funahashi; Y Arita; M Takahashi; M Matsuda; Y Okamoto; H Iwahashi; H Kuriyama; N Ouchi; K Maeda; M Nishida; S Kihara; N Sakai; T Nakajima; K Hasegawa; M Muraguchi; Y Ohmoto; T Nakamura; S Yamashita; T Hanafusa; Y Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

5.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.

Authors:  K Hotta; T Funahashi; N L Bodkin; H K Ortmeyer; Y Arita; B C Hansen; Y Matsuzawa
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

6.  Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

Authors:  C Weyer; T Funahashi; S Tanaka; K Hotta; Y Matsuzawa; R E Pratley; P A Tataranni
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

7.  Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice.

Authors:  Hua V Lin; Ja-Young Kim; Alessandro Pocai; Luciano Rossetti; Lawrence Shapiro; Philipp E Scherer; Domenico Accili
Journal:  Diabetes       Date:  2007-05-02       Impact factor: 9.461

8.  Decreased plasma adiponectin concentrations in women with dyslipidemia.

Authors:  Miyao Matsubara; Shoji Maruoka; Shinji Katayose
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

9.  Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome.

Authors:  Hidehiko Kondo; Iichiro Shimomura; Yuko Matsukawa; Masahiro Kumada; Masahiko Takahashi; Morihiro Matsuda; Noriyuki Ouchi; Shinji Kihara; Toshiharu Kawamoto; Satoru Sumitsuji; Tohru Funahashi; Yuji Matsuzawa
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors:  T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

View more
  10 in total

1.  Associations among serum pro- and anti-inflammatory cytokines, metabolic mediators, body condition, and uterine disease in postpartum dairy cows.

Authors:  Ramanathan K Kasimanickam; Vanmathy R Kasimanickam; Jesse R Olsen; Erin J Jeffress; Dale A Moore; John P Kastelic
Journal:  Reprod Biol Endocrinol       Date:  2013-11-09       Impact factor: 5.211

Review 2.  Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2014-06-23       Impact factor: 9.951

3.  Effect of physiological determinants and cardiac disease on plasma adiponectin concentrations in dogs.

Authors:  C Damoiseaux; A-C Merveille; E Krafft; A M Da Costa; S Gomart; P Jespers; C Michaux; C Clercx; C Verhoeven; K Mc Entee
Journal:  J Vet Intern Med       Date:  2014-10-13       Impact factor: 3.333

4.  Cardiac and Metabolic Variables in Obese Dogs.

Authors:  M Tropf; O L Nelson; P M Lee; H Y Weng
Journal:  J Vet Intern Med       Date:  2017-06-13       Impact factor: 3.333

5.  Higher neonatal growth rate and body condition score at 7 months are predictive factors of obesity in adult female Beagle dogs.

Authors:  Lucie Leclerc; Chantal Thorin; John Flanagan; Vincent Biourge; Samuel Serisier; Patrick Nguyen
Journal:  BMC Vet Res       Date:  2017-04-13       Impact factor: 2.741

6.  A Systematic Review and Meta-Analysis of Serum Adiponectin Measurements in the Framework of Dog Obesity.

Authors:  Alberto Muñoz-Prieto; José Joaquín Cerón; Silvia Martínez-Subiela; Vladimir Mrljak; Asta Tvarijonaviciute
Journal:  Animals (Basel)       Date:  2020-09-14       Impact factor: 2.752

7.  Supplementing five-point body condition score with body fat percentage increases the sensitivity for assessing overweight status of small to medium sized dogs.

Authors:  Gebin Li; Peter Lee; Nobuko Mori; Ichiro Yamamoto; Koh Kawasumi; Hisao Tanabe; Toshiro Arai
Journal:  Vet Med (Auckl)       Date:  2012-08-24

8.  Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome.

Authors:  Asta Tvarijonaviciute; Jose J Ceron; Shelley L Holden; Daniel J Cuthbertson; Vincent Biourge; Penelope J Morris; Alexander J German
Journal:  BMC Vet Res       Date:  2012-08-28       Impact factor: 2.741

9.  Ratiometric Measurements of Adiponectin by Mass Spectrometry in Bottlenose Dolphins (Tursiops truncatus) with Iron Overload Reveal an Association with Insulin Resistance and Glucagon.

Authors:  Benjamin A Neely; Kevin P Carlin; John M Arthur; Wayne E McFee; Michael G Janech
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-20       Impact factor: 5.555

10.  Influence of macronutrient composition of commercial diets on circulating leptin and adiponectin concentrations in overweight dogs.

Authors:  Niels Roderick Blees; Jeannette Wolfswinkel; Hans Sjoerd Kooistra; Ronald Jan Corbee
Journal:  J Anim Physiol Anim Nutr (Berl)       Date:  2019-12-26       Impact factor: 2.130

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.